Security Snapshot

Dermata Therapeutics, Inc. - Common stock, par value $0.0001 per share (DRMA) Institutional Ownership

CUSIP: 249845405

13F Institutional Holders and Ownership History from Q2 2024 to Q3 2025

13F reference period

n/a

Institutions Reporting

Shares (Excl. Options)

n/a

Price

$0.70

The headline uses the Q2 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended.

Save this security page for your next review

Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.

Create free account and return here Sign in and return here Review latest holder period
Security type / class
Equity / Common stock, par value $0.0001 per share
Symbol
DRMA on Nasdaq
Shares outstanding
4,233,387
SEC-reported price per share
$0.70
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source

Key facts

  • DRMA - Dermata Therapeutics, Inc. - Common stock, par value $0.0001 per share is tracked under CUSIP 249845405.
  • 13F reference-period holder data is not available.
  • 3 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder data for the Q2 2026 reference period is not available.
  • Available periods remain in the history table; they do not substitute for the headline period.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Schedule 13D/G

Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.

Open SEC evidence

Security key

249845405

13F reference period

n/a

13F holders

13D/G owners

3

CIK / CUSIP context first

DRMA full holder history Dermata Therapeutics, Inc. SEC filings Dermata Therapeutics, Inc. company facts Dermata Therapeutics, Inc. insider transactions

Broader feeds

Latest 13F filings Latest 13D/G filings All securities

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
3
Security
DRMA
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ARMISTICE CAPITAL, LLC 10% 0% $820,109 +$607,264 1,065,076 +285% Armistice Capital, LLC 31 Mar 2025
PROEHL GERALD T 13% $619,155 804,098 PROEHL GERALD T 27 Mar 2025
INTRACOASTAL CAPITAL, LLC 5% -8.5% $147,872 +$44,931 211,246 +44% Mitchell P. Kopin 31 Mar 2026

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
6
Headline period
n/a
Rows shown
1-6 of 6
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q3 0 $0 -$297,499 $0.70 0
2025 Q2 508,154 $297,499 -$7,049 $0.58 10
2025 Q1 518,513 $561,194 +$512,021 $1.08 8
2024 Q4 45,529 $61,465 +$51,415 $1.35 6
2024 Q3 6,444 $10,568 -$65,071 $1.64 4
2024 Q2 32,770 $78,254 +$78,254 $2.39 6
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .